Clinical Trials Directory

Trials / Completed

CompletedNCT01744457

Reproducibility of Tearfilm Osmolarity Measurements Using TearLab® in Patients With Dry Eye Syndrome and Healthy Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
45 Years – 80 Years
Healthy volunteers
Accepted

Summary

Dry Eye Syndrome (DES) is a common condition that affects approximately 20% of adults aged 45 and older. Although several clinical tests for the diagnosis and monitoring of DES are available, currently no gold standard for the assessment of DES exists. It has, however, been hypothesized that the assessment of tear film osmolarity may be a new and promising approach of an objective and non-invasive method for diagnosis and monitoring of treatment success. Recently, a new commercially available instrument (TearLab®, OcuSens Inc, San Diego, USA) for the assessment of tear film osmolarity has been introduced. This instrument allows for the easy and non-invasive determination of tear film osmolarity. Unfortunately, no data about reproducibility are yet available. Consequently, the current study sets out to investigate the short time reproducibility of tear film osmolarity measurements using the TearLab® instrument.

Conditions

Interventions

TypeNameDescription
DEVICEMeasurement of tear film osmolarity with the TearLab® instrument
OTHERSchirmer I test
OTHERTear break up time
DEVICEOptical Quality Analysis SystemMeasurement of the objective scattering index (OSI)
OTHEROcular Surface Disease Index

Timeline

Start date
2011-02-01
Primary completion
2012-02-01
Completion
2012-06-01
First posted
2012-12-06
Last updated
2012-12-06

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01744457. Inclusion in this directory is not an endorsement.